Literature DB >> 22259655

Reciprocal responses of fibroblasts and melanocytes to α-MSH depending on MC1R polymorphisms.

Hedwig Stanisz1, Markus Seifert, Wolfgang Tilgen, Thomas Vogt, Knuth Rass.   

Abstract

The melanocortin 1-receptor (MC1R) exhibits several variants in form of single nucleotide polymorphisms (SNPs) that are known to differentially regulate melanocyte function. However, whether and how MC1R polymorphisms also affect fibroblast function has not been investigated so far.Therefore we measured intracellular cyclic adenosine monophosphate (cAMP) concentrations and cellular proliferation upon stimulation with alpha-melanocyte stimulating hormone (α-MSH) in eight different human fibroblast and melanocyte cell lines with wild type and different MC1R SNPs.We found that fibroblasts, as well as melanocytes, show differences in MC1R function depending on the MC1R genotype. MC1R stimulation with α-MSH in wild type (MC1R(wt)) melanocytes results in an increase of intracellular cAMP and cellular proliferation. In contrast, MC1R(wt) fibroblasts react with a decrease of intracellular cAMP and proliferation. In MC1R polymorphic fibroblasts (R163Q, R151C and V60L) both effects are significantly alleviated. Similar, but inverse effects could be found in MC1R polymorphic melanocytes (R142H and V92M) with a significantly lower cAMP increase and proliferation rate compared to MC1R(wt) melanocytes.Our results indicate that the MC1R displays reciprocal growth responses in melanocytes and fibroblasts, depending on the MC1R genotype. Thus, the MC1R seems to be not solely important for the skin pigmentary system, but also for the fibroblast function, and might influence different processes of the dermal compartment like wound healing, fibrosis and keloid formation.

Entities:  

Keywords:  MC1R polymorphisms; cAMP; fibroblasts; melanocytes; proliferation; α-MSH

Year:  2011        PMID: 22259655      PMCID: PMC3256344          DOI: 10.4161/derm.3.4.17454

Source DB:  PubMed          Journal:  Dermatoendocrinol        ISSN: 1938-1972


  41 in total

1.  Interactive effects of MC1R and OCA2 on melanoma risk phenotypes.

Authors:  David L Duffy; Neil F Box; Wei Chen; James S Palmer; Grant W Montgomery; Michael R James; Nicholas K Hayward; Nicholas G Martin; Richard A Sturm
Journal:  Hum Mol Genet       Date:  2004-01-06       Impact factor: 6.150

2.  Racial differences in the incidence of treatment for end-stage renal disease.

Authors:  S G Rostand; K A Kirk; E A Rutsky; B A Pate
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

3.  Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides.

Authors:  Z Abdel-Malek; V B Swope; I Suzuki; C Akcali; M D Harriger; S T Boyce; K Urabe; V J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

4.  alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?

Authors:  Agatha Kokot; Anca Sindrilaru; Meinhard Schiller; Cord Sunderkötter; Claus Kerkhoff; Beate Eckes; Karin Scharffetter-Kochanek; Thomas A Luger; Markus Böhm
Journal:  Arthritis Rheum       Date:  2009-02

5.  Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: Steady-state retention of mutant forms in the proximal golgi.

Authors:  Berta L Sánchez-Laorden; Cecilia Herraiz; Julio C Valencia; Vincent J Hearing; Celia Jiménez-Cervantes; José C García-Borrón
Journal:  J Cell Physiol       Date:  2009-09       Impact factor: 6.384

6.  Screening of human primary melanocytes of defined melanocortin-1 receptor genotype: pigmentation marker, ultrastructural and UV-survival studies.

Authors:  J Helen Leonard; Lisa H Marks; Wei Chen; Anthony L Cook; Glen M Boyle; Darren J Smit; Darren L Brown; Jennifer L Stow; Peter G Parsons; Richard A Sturm
Journal:  Pigment Cell Res       Date:  2003-06

7.  Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis.

Authors:  Ashley D Beall; Paul J Nietert; Marian H Taylor; Holly C Mitchell; Stephanie R Shaftman; Richard M Silver; Edwin A Smith; Marcy B Bolster
Journal:  J Rheumatol       Date:  2007-05-15       Impact factor: 4.666

8.  Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations.

Authors:  Dominique Scherer; Eduardo Nagore; Justo Lorenzo Bermejo; Adina Figl; Rafael Botella-Estrada; Ranjit Kumar Thirumaran; Sabrina Angelini; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

9.  Melanocortin 1 receptor variants in an Irish population.

Authors:  R Smith; E Healy; S Siddiqui; N Flanagan; P M Steijlen; I Rosdahl; J P Jacques; S Rogers; R Turner; I J Jackson; M A Birch-Machin; J L Rees
Journal:  J Invest Dermatol       Date:  1998-07       Impact factor: 8.551

10.  Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone.

Authors:  Markus Böhm; Michael Raghunath; Cord Sunderkötter; Meinhard Schiller; Sonja Ständer; Thomas Brzoska; Thomas Cauvet; Helgi B Schiöth; Thomas Schwarz; Thomas A Luger
Journal:  J Biol Chem       Date:  2003-11-28       Impact factor: 5.157

View more
  6 in total

1.  Hormones and skin: A never ending love story!

Authors:  Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2011-10-01

2.  LINC00937 suppresses keloid fibroblast proliferation and extracellular matrix deposition by targeting the miR-28-5p/MC1R axis.

Authors:  Jing Wan; Xiao-Lei He; Qi-Chao Jian; Zhi-Feng Fan; Ying Shi; Long-Fei Luo
Journal:  Histol Histopathol       Date:  2021-08-23       Impact factor: 2.303

3.  Race and Melanocortin 1 Receptor Polymorphism R163Q Are Associated with Post-Burn Hypertrophic Scarring: A Prospective Cohort Study.

Authors:  Ravi F Sood; Anne M Hocking; Lara A Muffley; Maricar Ga; Shari Honari; Alexander P Reiner; Ali Rowhani-Rahbar; Nicole S Gibran
Journal:  J Invest Dermatol       Date:  2015-06-01       Impact factor: 8.551

Review 4.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

5.  Therapeutic senescence via GPCR activation in synovial fibroblasts facilitates resolution of arthritis.

Authors:  Trinidad Montero-Melendez; Ai Nagano; Claude Chelala; Andrew Filer; Christopher D Buckley; Mauro Perretti
Journal:  Nat Commun       Date:  2020-02-06       Impact factor: 14.919

6.  Finasteride inhibits melanogenesis through regulation of the adenylate cyclase in melanocytes and melanoma cells.

Authors:  Jae Ok Seo; Silvia Yumnam; Kwang Won Jeong; Sun Yeou Kim
Journal:  Arch Pharm Res       Date:  2018-02-03       Impact factor: 4.946

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.